NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Remagine Labs

Remagine Labs

Private
MelbourneHealthcare & Life Scienceshttps://www.remaginelabs.com/

Last Round

Pre Seed

Aug 4, 2025

Total Funding Raised

$3.16M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Remagine Labs is a therapeutic devices company developing a wearable, electronically controlled drug delivery system for chronic conditions like epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Biotechnology, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

transdermal drug deliverywearable patchdrug delivery platformiontophoresissmart patchdrug-device combinationprogrammable dosingelectro-pharmaceuticalwearable medical deviceneurological disordersprecision medicineepilepsy treatmentessential tremorbiopharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remagine Labs Comparables

Compare Remagine Labs with similar companies based on industry and business-model similarity.

Remagine Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ategenos Pharmaceuticals
83%
Biotts
72%
Nemaura Pharma
71%

Remagine Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 4, 2025
GrantMar 8, 2024

Key People

Founding team and executive leadership

Patrick Kelly

Chief Executive Officer

Executive Team

Remagine Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 235% to 937.

  • Dec 8, 2025

    Monthly visitors grew 48% MoM.

Remagine Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remagine Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remagine Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range6
Year FoundedN/A
Last FundingAug 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.